Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Tenax Therapeutics Q4 EPS $(11.84) Misses $(8.14) Estimate

Author: Benzinga Newsdesk | March 28, 2024 05:01pm
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(11.84) per share which missed the analyst consensus estimate of $(8.14) by 45.45 percent. This is a 83.74 percent increase over losses of $(72.80) per share from the same period last year.

Posted In: TENX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist